{"name":"Jecho Biopharmaceuticals Co., Ltd.","slug":"jecho-biopharmaceuticals-co-ltd","ticker":"","exchange":"","domain":"jechobiopharmaceuticals.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE8tbVBldXBoQmduVmlHVmEteWdyVmVLVjhjc2xQWE5KbEdrbFFseTYxVmZlM2IwNzNJS2xtdXJMSzl0MTVfSzNDTUdkTFB6WXBvaTRPd1gxRnhuSFFSRDl4Uy1B?oc=5","date":"2025-02-06","type":"pipeline","source":"PNAS","summary":"Rapid restoration of potent neutralization activity against the latest Omicron variant JN.1 via AI rational design and antibody engineering - PNAS","headline":"Rapid restoration of potent neutralization activity against the latest Omicron variant JN.1 via AI rational design and a","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOQlZXd1VxLTdPNE5LSTZJd2RTbGFrSkliaG1fUlczbjRzM2hiZDdVRllwWFlZU2t2OEpUblFzeHBoc3l1Qjd4QUZkbnhDMmJWNTNfdnZYczJTZTg3TS1KbmRJWFdtWUxCSlFHS3ZQSVptOUdjRUtGc0RwN3ROVHBkcTduZDVNWVJsZzBERUJld0xXYlk?oc=5","date":"2022-02-22","type":"pipeline","source":"Frontiers","summary":"IgG-like Bispecific Antibody CD3×EpCAM Generated by Split Intein Against Colorectal Cancer - Frontiers","headline":"IgG-like Bispecific Antibody CD3×EpCAM Generated by Split Intein Against Colorectal Cancer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}